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Background: Prion diseases are neurodegenerative dis- 
orders that appear to be due to a conformational 
change, involving the conversion of ol-helices in the 
normal, cellular isoform of the prion protein (PrPc) to 
p-structure in the infectious scrapie form (PrPsc). One 
form of Gerstmann-Straussler-Scheinker syndrome 
(GSS), an inherited prion disease, is caused by mutation 
ofAlall7 of PrPC toVa1. We therefore set out to evalu- 
ate the effects of this mutation on the stability of the 
PrPc form. 
Results: We have performed molecular dynamics simula- 
tions of a portion of the PrPc sequence (residues 109-122, 
termed HI) that is proposed to figure prominently in the 
conversion of PrPC to PrPSC. In particular, beginning with 
Hl in the cc-helical state, the conformational conse- 
quences of sequence changes at position 117 were investi- 
gated for six hydrophobic mutations. Of these, only theVal 
mutation was helix-destabilizing. Portions of this mutant 
peptide adopted and retained an extended conformation 
during a 2 ns simulation of the peptide in water. 
Conclusions: The conformational transitions and struc- 
tures observed in the simulation of the mutant peptide 
with Val at position 117 provide insight into the possible 
early steps in the conversion of PrPc to PrPsc. 
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Introduction 
Prions are the infectious pathogens that cause a number 
of transmissible neurodegenerative diseases in mammals 
[l]. In humans, four prion diseases have been identified: 
Kuru [a], Creutzfeldt-Jakob disease (CJD), Gerstmann- 
Straussler-Scheinker disease (GSS) and fatal familial 
insomnia (FFI) [3]. Various forms of these diseases can 
occur sporadically, in an inherited form, or through 
infection [4,5]. The essential constituent of prions is the 
scrapie prion protein (PrPsc), which is chemically indis- 
tinguishable from the normal, cellular protein (PrPc) but 
exhibits distinct secondary and tertiary structure [6-121. 
Much experimental evidence suggests that PrPsc assists 
in the conversion of PrPc to PrPSC, thus allowing prions 
to replicate [1,12-141. 
Fourier transform infrared (FTIR) and circular dichro- 
ism (CD) spectroscopy studies revealed that the confor- 
mational transition of PrPC to PrPSC involves the 
conversion of ol-helices to P-sheet structure [ll]. 
Unfortunately, high-resolution structural studies (such 
as X-ray crystallography and multi-dimensional nuclear 
magnetic resonance (NMR) spectroscopy) of PrPC and 
PrPSC have been thwarted by aggregation of the protein 
during purification. As a result, structural data are 
mainly limited to what can be deduced from FTIR and 
CD [8,11,15-171. 
As there is no experimentally determined three-dimen- 
sional structure for PrPc or PrPsc, Cohen and co-workers 
have used algorithms that predict protein structure to 
generate models of the PrPc conformation [lS,lS]. The 
favored model resulting from this work is a four-helix 
bundle (Fig. l), which is supported but not defined by the 
spectroscopic data [18]. In this model, the first of the pre- 
dicted helices lies between residues 109-122 (Hl) (see 
Figs 1,2) [15]. The isolated Hl peptide, however, forms 
p-structure in aqueous solution [15], although it does 
adopt a-helical structure in hexafluoroisopropyl alcohol 
(HFIP) [15,19]. Two-dimensional NMR studies of a 
longer PrP peptide from Syrian hamster (SHa) consisting 
of residues 90-145, which includes Hl, suggest that 
Hl is a-helical under aqueous conditions [20]. The 
SHa peptide forms a polymeric aggregate rich in 
p-structure after a matter of days, however [20]. 
Gerstmann-Straussler-Scheinker disease is caused by a 
mutation near the center of the Hl helix involving substi- 
tution ofAla 17 withVal (the Al 17V mutation; see Fig. 1) 
[21-231. The position of this substitution provides an 
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Fig. 1. A predicted three-dimensional model of PrPC (residues 
109-218) [18]. The HI helix is shown in cyan and specific 
residues are colored and labeled. 
opportunity to test whether the A117V mutation has a 
destabilizing effect on the helical state, facilitating a confor- 
mational change. To this end, we have performed various 
molecular dynamics simulations of the Hl prion peptide 
in solution to study the effect of the Al 17V mutation and 
other hydrophobic mutations at position 117. 
Molecular dynamics has become a common technique 
for simulating the motion of proteins (reviewed by 
Daggett and Levitt [24]) and peptides (reviewed by 
Brooks and Case [25]). To use this method, one must 
have a well defined starting structure, preferably an X-ray 
or NMR structure in the case of proteins. This can be a 
problem for small peptides since they tend to be confor- 
mationally heterogeneous and generally one uses models 
built on idealized conformations to begin a simulation. 
This technique uses a potential energy function whose 
parameters have been derived to reproduce structures 
and energy trends in various model systems. Such a force 
field can be applied to study a variety of different mol- 
ecules, including small organic molecules, peptides, lipids, 
carbohydrates, proteins, RNA and DNA. In molecular 
dynamics simulations, the atoms move due to their own 
kinetic energy and the forces exerted upon them by all 
other atoms. During the simulation one can monitor 
specific interactions both geometrically and energetically 
to investigate structural transitions and the mechanism by 
which they occur. This last point makes the method par- 
ticularly attractive for investigating sequence effects on 
the structtire of the Hl prion peptide. 
Our underlying hypothesis for these simulation studies is 
that the Hl sequence is helical in PrPc. Since we are 
investigating isolated helices, we cannot address the 
importance of interactions between Hl and the rest of 
the protein. By making mutations to the helical peptide, 
however, we can investigate the stability, structure and 
conformational transitions of the peptide that may be 
relevant to PrPSC formation in the intact protein. The 
term stability refers to the proclivity of the helical struc- 
ture to unwind (i.e. the rate of unwinding) and not the 
thermodynamic stability. Simulations of the wild-type 
sequence and various mutants (Al 17V, Al 171, Al 17L, 
Al 17F and Al 17NLE; NLE is norleucine, which has an 
n-butyl group as its side chain and is a common compu- 
tational and experimental surrogate for methionine) 
suggest that the A117V mutation destabilizes the helix, 
while the other mutations do not.These simulations lend 
support to the contention that inherited prion diseases 
are a result of a change in the equilibrium between the 
PrPC and PrPSC isoforms of the protein, likely due to an 
acceleration in the rate of formation of PrPsc [13,14]. 
Results 
The molecular dynamics of each of the six Hl peptides 
were simulated for 2.0 ns. Plots of a-helix content versus 
time are shown in Figure 3 and contour plots of the 
a-helix content versus time for each residue are shown 
in Figure 4. Each of these simulations will be discussed 
below. Table 1 displays a summary of the helix content 
averaged over the final 0.2 ns for each of the simulations. 
Wild-type peptide 
Throughout the 2 ns simulation, the wild-type Hl 
peptide maintained a high percentage of helical struc- 
ture, seldom falling below 60 % (Fig. 3a). A completely 
helical structure was never obtained during the simula- 
tion as seen by the area of low-percentage helical struc- 
ture in the plot for residues Glyl19 and Ala120 (Fig. 4a). 
A small, yet strong, hydrophobic cluster near the carboxyl 
terminus formed between the isopropyl groups of 
Va1121 andVal122 and the methyl group ofAlal17. For 
this interaction to occur, the dihedral angles of Gly119 
and Ala120 left the a-helical range to accommodate the 
strain placed on the backbone. The resulting structure 
had a partially uncoiled carboxyl terminus and an 
increase in i+i+5 hydrogen bonds (i refers to the posi- 
tion of a residue in the helix. i+5 is a residue 5 positions 
towards the carboxyl terminus). 
Ace-Met-Lys-His-Met-Ala-Gly-Ala-Ala-Ala-Ala-Gly-Ala-VaI-VaI-Amd 
109 110111 112 113 114 115116 1~7118119 120 121 122 
Fig. 2. The sequence of the HI prion 
peptide, including acetyl and amide 
caps. The asterisk indicates the position 
of the mutation. 
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Fig. 3. Percentage a-helical content as a function of time at 298 K for the HI prion peptides: (a) wild type, (b) Al 17V mutant, (c) Al 171 
mutant, (d) Al 17L mutant, (e) Al 17NLE mutant and (f) Al 17F mutant. 
There were two significant disruptions to the a-helix solvation of the side chain of Metl12, moving it away 
during the simulation. The first of these occurred from the cluster. 
slightly before 1.4 ns and involved loss of structure 
around LysllO and Met112 (Fig. 4a), such that the side The other significant loss of helix content occurred at 
chain of Met112 was incorporated into the carboxy- -1.6 ns and involved kinking of the helix due to side- 
terminal hydrophobic cluster. The distorted helical chain clustering between Metl12,Val121 and&l122 over 
structure was short-lived and it was restored through the top of the methyl group ofAlall7.This arrangement 
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Fig. 4. Contour plots of percentage a-helical structure versus residue number and time for the HI prion peptides. The contour plots 
display ‘valleys’ and ‘holes’ where a-helix content drops. Shown here are: (a) wild type, (b) Al 17V mutant, (c) Al 171 mutant, (d) 
Al 17L mutant, (e) Al 17NLE mutant and (f) Al 17F mutant. Shades are defined as follows: white (loo-83 % a-helix), light gray 
(83-67 %), medium gray (67-50 %), moderate gray (50-33 %), dark gray (33-l 7 %), black (17-O %). If all residues of the peptide were 
to remain helical, the plot would be white and devoid of contours. 
left the main-chain atoms ofAla 13, Glyl14 and Ala1 18 
accessible to solvent. This conformation was present for 
-0.13 ns before Va1121 and Va1122 moved away and 
reformed the stable, but smaller hydrophobic cluster 
described above. 
Throughout the simulation, the peptide adopted a struc- 
ture that appeared to be a ‘relaxed helix’ near the car- 
boxy1 terminus. Unlike an ideal or-helix, which contains 
i+i+4 and i+i+3 hydrogen bonds, the wild-type 
Hl peptide contained i+i+4 hydrogen bonds at its 
amino terminus and many i+i+5 hydrogen bonds at its 
carboxyl terminus (Fig. 5).These i+i+5 hydrogen bonds 
helped to stabilize the partial uncoiling of the backbone 
during the clustering of residues Ala117, Va1121 and 
Va1122. However this ‘relaxed’ helical structure was not 
unique to the wild-type sequence; all the mutants 
except for A117V (which adopted a novel structure) 
formed a significant number of these hydrogen bonds at 
the carboxyl terminus. 
Al 17V peptide 
The a-helix was unstable when Ala1 17 was mutated toVal 
(Fig. 3b). Over the first nanosecond of the simulation, the 
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Table 1. Summary of HI prion peptide simulations performed 
and their associated cu-helical content+. 
Peptide a-Helical 
content 
Wild type 83 
A117V 39 
Al 1 7Vb 41 
A1171 78 
A117L 82 
A117Lb 81 
A117NLE 81 
A117F 75 
aThe a-helical content is the percentage of residues that con- 
tained a-helical main-chain dihedral angles averaged over the 
last 0.2 ns of the simulations. In order for a residue to be con- 
sidered helical it had to be within a consecutive sequence of 
three or more residues with a-helical dihedral angles. One 
residue equals 7 % of the peptide. The standard deviation in 
the helical content was -15 %. 
bSecond simulations were performed using slightly different 
conditions (see Materials and methods). 
A117V peptide experienced a steady decline in helix 
content, owing to the total unwinding of one turn of the 
a-helix.The second nanosecond of the simulation involved 
the stabilization of this unwound region of the peptide. 
The starting structure for the simulation contained a 
very tight helix at the carboxyl terminus with many 
i-+i+3 hydrogen bonds (117 NH-114 0, 118 NH-115 
0,119 NH-116 0,120 NH-117 0 and 121 NH-118 
0). These hydrogen bonds quickly shifted to i-i+4 
hydrogen bonds except for 121 NH-117 0. The 
P-branched isopropyl groups ofVall17 andVa1121 pre- 
vented the formation of main-chain hydrogen bonding 
between these residues. As a result of steric clashes 
between Vail 17 and Va1121, the latter moved above the 
carboxyl terminus of the helix. 
The distortion of Va1121 resulted in a large opening for 
the access of water, and at 0.15 ns, a water molecule 
inserted itself and became a hydrogen bond acceptor for 
the amide hydrogens of Va1121, Va1122 and the amide 
cap. Gly119 then became more mobile and over the next 
0.25 ns made a transition to a left-handed helical confor- 
mation, which pointed all residues after Gly119 away 
from the helix and into solution (Fig. 6). 
From 0.9 to 1.3 ns, the peptide formed hydrophobic 
clusters that stabilized its new, partially unwound 
conformation. At 0.9 ns, Met1 12 formed a cluster with 
Ala116 and Vall17 that broke the hydrogen bonds 
involving Met109, Hislll, Gly114 and Ala115 and left 
the main chain accessible to solvent. At 1 .O ns, the side 
chain of Va1121 on the unwound portion of the peptide 
formed a cluster with the extended methylene chain of 
LysllO that persisted for 0.3ns and further perturbed 
the helical structure. 
At 1.3 ns,Ala120 adopted P-strand dihedral angles (data 
not shown).This new conformation for Ala120 had two 
effects on the peptide. First, the amide hydrogen of 
Ala120 was able to hydrogen bond to the carbonyl 
oxygen of Gly114, which decreased its rotational mobil- 
ity. Second, the new dihedral angles of Ala120 rotated 
the chain of unwound residues and broke up theVa1121 
and Lysl 10 cluster. The disruption of this cluster allowed 
LysllO to form main-chain hydrogen bonds with 
Gly114, thus repairing the exposed helix backbone and 
disrupting the hydrophobic cluster composed of residues 
112, 116 and 117. Furthermore, the rotation of the 
extended residues pointed the carbonyl oxygens of these 
residues down towards the amino terminus, resulting in 
a stable interaction with the positive charge on the Lys 
side chain. 
Over the last 0.4 ns of the simulation, Ala113 and 
Val117 displayed a large decline in helicity (Fig. 4b). 
Despite this drop, the main-chain hydrogen bond 
between the two residues increased in strength; the 
hydrogen bond was intact 29 % of the time between 
1.5-1.6 ns and above 90% of the time for the remain- 
der of the simulation.The adjustment in the backbone 
of these two residues protected the hydrogen bond 
from solvent by centering it behind the methyl groups 
of the alanines 113, 116 and 118 and the side chain of 
Vall17. Furthermore, the distortion of Ala1 13 moved 
the side chain of Met112 away from the side chain of 
Val117, leading to a 33 % increase in the fluctuation of 
the side-chain dihedral angle x1 of Val117. 
One must be cautious in basing conclusions on the 
results of only one simulation. Therefore, another simu- 
lation of the A117V peptide was performed using 
slightly different conditions .(see Materials and 
methods). While details of the trajectory differed, they 
were very similar overall. The helical structure was 
again destabilized upon introduction of Val (Table 1). 
In this simulation, there was an unwinding of the helix 
beginning at Gly114 leading to a fluctuating turn struc- 
ture with little resemblance to the initial structure (data 
not shown). 
Al 171 peptide 
In comparison to the Al 17V simulation, helical structure 
was well maintained in the A1171 simulation (Table 1 
and compare Figs 3a,b,c).Throughout most of the simu- 
lation, the Al 171 mutant adopted ‘relaxed helix’ confor- 
mations as described for the wild-type peptide. One 
interesting thing to note in the plot was the large spike at 
0.93 ns where the helical structure dropped close to 0 
(Fig. 3~). The loss of structure centered around Met112 
because it was incorporated into the small hydrophobic 
cluster composed of Ile117,Val121 andVa1122 (Figs 4,7). 
This clustering exposed the other side of the helix to 
solvent (LysllO, Hislll, Gly114, Ala115 and Gly119). 
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Fig. 6. Snapshots from the Al 17V simu- 
lation illustrating unwinding of the car- 
boxy1 terminus of the helix. In the first 
0.4 ns, solvation of the last turn of the 
helix occurred with a 90” rotation of the 
Valll7 side chain. The center and right 
structures show residues 120-l 22 
pointing out into solution. The adoption 
of a left-handed helix conformation by 
Glyl 19 and p-structure by Ala120 
allowed for this conformation. 
Considering the final structure in the 
context of the model in Figure 1 sug- 
gests that the carboxyl terminus of HI 
would point into solution and open the 
hydrophobic core to solvent. 
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This arrangement, however, was not stable; the helical 
content recovered rapidly with the removal of Met112 
from the cluster. 
Slightly before 1.2 ns, the helical conformation of the 
Al 171 mutant experienced another large disruption. 
Here the dihedral angles of Ala113 became distorted, 
completely exposing the side chain of Ilel17.This distor- 
tion of the a-helix allowed the P-branched side chain of 
Ile117 more freedom to rotate. A 14 % increase was 
observed in the motion of the x1 angle of Ilel17. As seen 
in Figure 3c, this conformation was present for only 
-50 ps. After this point, the backbone dihedral angles of 
Ala1 13 returned to those of an a-helix. 
Al 17L peptide 
The A117L peptide maintained a high degree of 
helical structure throughout the simulation, ranging 
between 70-85 % (Table 1, Fig. 3d). Unlike the Al 171 
mutation, the A117L simulation did not experience 
any large disruptions in helical structure, but instead it 
suffered three very small distortions.There was a -15 % 
reduction in helical content at each of these time 
points, which corresponds to two residues leaving the 
helical geometry. 
The loss of helical content for the Al 17L simulation was 
centered around the amino terminus and Met109 (Fig. 
4d). The distortions experienced were associated with 
Met109 forming contacts with the extended methylene 
chain of LysllO and Leul17. This was accomplished by 
distortion of the main chain around residues 109 and 
110 such that the amino terminus moved upwards 
towards Leul17. A second simulation of A117L, per- 
formed under slightly different conditions (see Materials 
and methods), also showed a high degree of helical struc- 
ture (Table 1) and was consistent with the description of 
the fine structure presented above. 
Al 17NLE peptide 
The first 1 .O ns and the last 0.6 ns of the Al 17NLE sim- 
ulation were very similar to the wild-type simulation 
(Table 1, Fig. 3). From 1 .O to 1.3 ns, however, the 
peptide displayed dramatically different behavior. The 
helical structure of Al 17NLE changed precipitously at 
-1.1 ns. Prior to this, the helix was slightly distorted, as 
in the wild-type simulation, with a small hydrophobic 
cluster consisting of Nle117, Va1121 and Va1122. This 
small cluster perpetuated the loss of structure in Glyl19 
and Ala120 (Fig. 4e). Concomitant with the large loss of 
structure at 1.1 ns, an extensive hydrophobic cluster 
formed which encompassed the side chains of Metl12, 
Nle117, Va1121 and Va1122 (Fig. 7). As a result of 
forming this cluster, one side of the helix collapsed and 
the other opened up, allowing solvation of the main- 
chain atoms of residues LysllO, Hislll, Glyl14,Ala115, 
Ala1 18 and Glyl19. 
After -1.1 ns there was a recovery of some of the 
helical structure. Previously, Glyl14 did not participate 
in hydrogen bonds and was highly mobile (Fig. 4e), 
however at -1.1 ns the amide hydrogens of Gly114 and 
Ala115 formed hydrogen bonds to the carbonyl group 
of Met109, decreasing the mobility of Gly114. With 
the stabilization of Gly114, the backbone of the helix 
was intact and the helical content increased (Fig. 3e). 
This conformation was still fairly mobile, however, as 
seen by the high fluctuation in the helical content over 
the next 0.2 ns. 
Al 17F peptide 
One major difference between Phe and the other 
hydrophobic residues substituted is the introduction of 
an aromatic ring that can act as another hydrogen-bond 
acceptor [26,27].This property had only a minor effect 
on the peptide structure, however, as briefly seen at 
0.5 ns of the simulation. At this point, a water bridge 
formed between the E-amino group of LysllO and the 
aromatic ring of Phel17, distorting the helix slightly. 
This structure was only observed once during the 
simulation, as the carboxy-terminal half of the helix 
eventually ‘relaxed’ to i+i+5 hydrogen bonds that posi- 
tioned LysllO on the opposite side of the helix from 
the Phe ring. 
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Af 171 at 0.92 ns A117NLE at 1.1 ns A117F at 1.7 ns 
Late in the simulation, the Al 17F mutant lost more than 
half of its helical structure. This loss correlated with the 
formation of another hydrophobic cluster similar to the 
one seen in the A1171 and A117NLE simulations. 
Shortly after 1.6 ns, the Met112 side chain shifted to 
interact directly with the ring of Phel17 (Fig. 7). The 
backbone of the helix was strained and the face of the 
helix opposite this cluster was extensively solvated. The 
main-chain hydrogen bonds of Met109, LysllO,Alal13, 
Gly114 and Ala118 were broken, creating a distorted 
helix reminiscent of the structure observed in the 
A117NLE simulation; the C, root-mean square devia- 
tion between A117F (1.75 ns) and A117NLE (1.06 ns) 
was 1.2 A (Fig. 7). For comparison, the root-mean square 
deviations between other structures were 2 1.6 A. An 
explanation for the low root-mean square deviation is 
that both peptides were distorted through a similar 
mechanism. In both cases, an extremely large hydropho- 
bic group was placed in the middle of the helix and pro- 
vided a nucleus for further clustering. Both simulations 
formed clusters involving residues Metl12, 117,Va1121 
andVa1122, which distorted the helix and left one face 
open to attack by water. 
Discussion 
Although the biological function of PrPC has yet to be 
determined, conversion to PrPSC is known to be a post- 
translational process [9,28,29]. Many investigators have 
resisted the idea that a protein alone could cause a trans- 
missible disease. Despite many years of investigation, no 
one has been able to identify co-factors or chemical 
modifications responsible for the conversion of PrPc to 
PrPSC [l,lO]. Although the existence of unidentified 
factors cannot be ruled out, it seems reasonable to assume 
that a conformational change in PrPC produces PrPsc. 
Thus, our working hypothesis is that the only difference 
between PrPC and PrPSc is the conformation of the 
protein [6-&l O-l 2,171. Environmental changes, the 
presence of biological co-factors, or mutations could 
Fig. 7. Three examples of the hydropho- 
bic clusters observed in the simulations. 
The coloring scheme is the same as that 
in Figure 6 to facilitate comparison. The 
clusters distort the helix and leave one 
face of the helix open to solvent. Each 
of these peptides has within its cluster 
the residues Met1 12, 117, Vall2 1, and 
Va1122. The instantaneous helix content 
from all three structures is below 40 % 
and reflects the lowest helix content 
during the simulations. 
then shift the equilibrium between the two forms of PrP 
and favor the development of prion diseases by destabi- 
lization of PrPc, stabilization of PrPsc, and/or by acceler- 
ation of PrPsc production. Unfortunately, high-resolution 
structural information for PrPC and PrPSC is not avail- 
able. FTIR and CD spectroscopies have provided some 
insight into prion protein structure, but the resolution of 
these methods is limited [8,11,15-171. 
Modeling studies represent a logical avenue for attempt- 
ing to characterize the structural and conformational 
properties of this system [ 15,181. In this modeling study, 
we have focused on the Hl peptide (Fig. l), as experi- 
mental studies of this fragment suggest that it has a 
central role in prion diseases [15,18,19,30]. We assume 
that the Hl section of PrPC is or-helical for the following 
reasons: (1) PrPC contains 42 % a-helical structure and 
only 3 % B-sheet structure [ll]; (2) an extended Hl 
peptide (residues 104-122) is a-helical in the solid state 
and in aqueous HFIP [30]; (3) the Hl peptide is (Y- 
helical in aqueous HFIP [15,19] and in aqueous SDS 
[20]; and (4) two-dimensional NMR studies of the SHa 
peptide (residues 90-145) identify helical structure in the 
Hl region [20]. 
To better understand this system and the conforma- 
tional sensitivity to changes in the sequence, we have 
performed molecular dynamics simulations of the Hl 
prion peptide with various amino-acid substitutions at 
residue 117. Our simulations provide a model of how 
this portion of the protein might respond to mutations. 
Although the peptides did not remain ideally o-helical 
throughout the 2.0 ns simulations, the wild type,Al171, 
Al 17L, A117NLE and A117F peptides retained high 
helix content. In contrast, substitution ofAlall7 byVa1, 
a known disease-causing mutation [21-231, led to 
destabilization of the helix and formation of an 
extended strand. By destabilization, we are speaking 
strictly of a kinetic effect and not a thermodynamic 
effect. To comment on the thermodynamics of the 
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system, we would require many more trajectories or a 
much longer simulation time to sample conformational 
space more effectively. We have completed preliminary 
studies of seven other mutations at position 117 
(A117P, A117D, A117S, A117T, A117W, A117E and 
A117G). In these cases, two mutations show a signifi- 
cant loss of detailed helical fine structure without a loss 
of average helical morphology (A117P, A117D), and 
another develops an extended structure in the carboxy- 
terminal region of the peptide (Al17S) (data not 
shown). As yet, not one of these mutant peptides 
exhibits the combination of structural distortions seen 
in the Al 17V simulations. Therefore, our results suggest 
that the conversion of a-helix to an extended structure 
in the Hl peptide could be involved in the conver- 
sion of PrPC to PrPSC, and that the A117V mutation 
facilitates such a conversion. 
In general, our simulations are a measure of the destabi- 
lization of the Hl helix and do not account for the 
effect of mutations on other conformations available to 
the peptide. Upon comparing our helix-destabilizing 
results with experiments on model helices, it was sur- 
prising that we found the Ile and Phe mutants in a 
helical conformation. In experimental studies, Val, Ile 
and Phe are helix destabilizing, while Ala, Leu and NLE 
can easily be incorporated into a helix [31,32]. For the 
A117V mutant, the loss of helical structure was due to 
its inability to form a hydrophobic cluster at its carboxyl 
terminus. The P-branched Val residue at position 117 
introduced steric and entropic barriers to forming the 
cluster. In contrast, the increased hydrophobicity of Ile 
and Phe made it possible to overcome these entropic 
barriers and prevent unwinding. 
The disruption of the o-helix upon replacement of Ala 
byVa1 suggests that the increase in size and hydropho- 
bicity of Val may elicit unfolding. However, comparison 
of the various simulations indicates that these factors are 
not enough to destabilize the o-helical conformation of 
this peptide. For example, all of the mutant residues are 
more hydrophobic and larger than both Ala andVa1, yet 
they were comparable to the wild-type peptide in terms 
of o-helical content. Instead, the branched P-carbon of 
Val created steric conflicts when the backbone was in an 
a-helical geometry and favored a more open conforma- 
tion. In contrast, the other P-branched mutant, Al 171, 
was able to form a hydrophobic cluster on one face of 
the o-helix that exploited the additional hydrophobicity 
of Ile overVa1. 
In the predicted model of PrPC (Fig. l), the side chain 
of 117 is pointed directly into the center of the four- 
helix bundle and contributes to the hydrophobic core 
[18]. Within the context of this structural model, our 
results suggest that not only would substitution ofAla by 
the largerVa1 presumably be unfavorable due to crowd- 
ing of the core but it would also facilitate unraveling of 
the carboxy-terminal end of the helix. This localized 
unfolding would result in the formation of an extended 
strand pointing into solution, exposing a portion of the 
hydrophobic core to solvent or causing a substantial 
rearrangement of the PrPC structure. A scenario for the 
early steps in intermolecular aggregation might be that 
the extended strand in A117V can interact with 
another PrPC molecule to stabilize an alternate confor- 
mation on the pathway to PrPSC. Such a scheme could 
yield spontaneous formation of disease-causing PrPSC in 
patients carrying the Al 17V mutation of GSS. However, 
our simulations do not take into account the longer- 
range interactions possible between the mutant residue 
and the hydrophobic core of PrPC, which must also be 
important in this process. 
Significance 
Prion diseases are rare neurodegenerative diseases 
that are believed to be caused by a conforma- 
tional transition of the normal prion protein 
(PrPc) to an abnormal, infectious form (PrPSc) 
[1,6-121. Current difficulties with protein purifi- 
cation and aggregation have prevented structural 
determination of the prion protein by X-ray crys- 
tallography or multi-dimensional NMR tech- 
niques. Consequently, theoretical methods have 
been employed to model the prion protein and its 
behavior [15,18]. Both theoretical and experi- 
mental studies suggest that residues 109-122 (Hl) 
of the prion protein are o-helical in PrPC and 
convert to p-structure in PrPSC. Mutation of 
Ala117 to Val within this putative helix leads 
to Gerstmann-Straussler-Scheinker syndrome, a 
human prion disease [21-231. 
The simulations presented here suggest that 
mutation of Ala to Val at position 117 destabilizes 
the Hl helix of PrPC. Due to steric conflicts in 
the helical state,Va1117 causes the carboxyl ter- 
minus of the peptide to unfold and form an 
extended strand. Simulations of mutants substi- 
tuted at this position with other hydrophobic 
residues (A1171, A117L, A117NLE and A117F) 
suggest that the A117V mutation is unique in its 
effects upon the Hl helix. Comparison of the 
helix simulations with the predicted three- 
dimensional model of PrPC suggests that distur- 
bance of the Hl helix by the mechanism 
identified with the A117V peptide may be an 
early step in the conversion of PrPC to PrPSC. 
This mechanism would expose the hydrophobic 
core to solvent and the extended strand of HI 
would be in a position to interact with neighbor- 
ing prion proteins, which might facilitate the 
conversion of other PrPC molecules. 
Materials and methods 
The human Hl prion peptide (residues 109-122) in an (Y- 
helical conformation was the initial starting point for the 
simulations (see Figs 1,2). All calculations were performed 
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using the program ENCAD [33] and a previously described 
force field [34-361. The amino terminus was acetylated and 
the carboxyl terminus was amidated, since experimental 
studies of this peptide had previously been done [15]. 
The helices were then subjected to 500 steps of steepest 
descent minimization in vacua so as to relieve any minor 
conformational conflicts. 
Each minimized structure was then placed into a rectangular 
box and water molecules were then added at a density of 
0.997 g cm-3 extending at least SA from any peptide atom. 
This resulted in the addition of approximately 1000 water 
molecules (the number differs slightly in the different simu- 
lations). Periodic boundary conditions and an 8 A non- 
bonded cutoff (with updates to the list every 5 steps) were 
employed throughout. The water molecules were then sub- 
jected to 1000 steps of conjugate gradient minimization. 
Molecular dynamics (1000 steps at 298 K) was then per- 
formed on the water molecules, followed by another 1000 
steps of conjugate-gradient minimization to further solvate 
the peptide. Subsequent to this, the peptide was minimized 
with 1000 steps of conjugate gradient minimization. Finally, 
the entire system was minimized for 1000 steps of conjugate 
gradient minimization. 
A molecular dynamics simulation was performed for 2.0 ns at 
298 K for each peptide. Each simulation consisted of lo6 steps 
of dynamics using a 2 fs time step for evaluating the potential 
function. Coordinates were saved every 100 time steps, or 
0.2 ps, for analysis. Each simulation required -270 h of com- 
puter time on a Silicon Graphics Indy workstation with an 
R4400 CPU. 
For analysis, the percentage of secondary structure was fol- 
lowed throughout the simulation. The backbone dihedral 
angles were monitored and were evaluated as being either 
a-helical, B-sheet, or other using a previously described 
method [37,38]. For a residue to be considered c-w-helical the 
following range of backbone dihedral angles had to be satisfied: 
-loo”<+<-30” and -8O”<@-5”. For P-strand conformations, 
the range was -170”<$<-50” and 80”<$<190”. The helix 
content plotted in Figure 3 also reflects the repeating nature of 
helical structure and requires that at least three consecutive 
residues fulfill the ($,$) criterion outlined above. Hydrogen- 
bond analysis was done using a distance cutoff of 2.6 A 
between the relevant donor and acceptor atoms. 
To ensure that the basic features observed during the simula- 
tion were reproducible, two particular peptides (A117V, and 
Al 17L) were simulated a second time under slightly different 
conditions. Al 17V and Al 17L were chosen because they are 
chemically similar and yet they show very different behavior 
in the simulations. In these cases, the initial in vacua mini- 
mization was omitted. This procedure yields a slightly differ- 
ent starting structure, which results in a different trajectory, 
and is similar to changing the random number seed or the 
heating protocol. 
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